7,534.15

+157.29

+2.13%

52,281.23

+995.50

+1.94%

25,185.26

+605.84

+2.46%

2,827.67

+73.57

+2.67%

4.8780

+0.0190

+0.39%

20.70

-4.94

-19.28%

4,115.60

+40.70

+1.00%

74,942.13

-711.73

-0.94%

Crude Oil Dec 26

87.87

-2.96

-3.26%

US Private Equity

10,772.76

+11.83

+0.11%

NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (STLN)

4.3100 +0.6900 (+19.06%)

As of 12:01:23 PM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Oncology Institute Q3 Earnings Call Highlights

MarketBeat 3d ago

STLN
+19.06%
Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates

Zacks 3d ago

STLN
+19.06%
ARMP
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

GlobeNewswire 3d ago

STLN
+19.06%
TOIIW
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call

GlobeNewswire 14d ago

STLN
+19.06%
TOIIW
Starling Oncology (STLN) Stock Gets Fair Value Boost On Capitated Revenue And Nexus Views

Simply Wall St. 24d ago

STLN
+19.06%
Starling Oncology to Participate in Wells Fargo Healthcare Conference

GlobeNewswire 2mo ago

STLN
+19.06%
TOIIW
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates

Zacks 3mo ago

STLN
+19.06%
AAWH
Geron (GERN) Reports Break-Even Earnings for Q3

Zacks 5d ago

GERN

STLN
+19.06%
Ultragenyx (RARE) Reports Q3 Loss, Lags Revenue Estimates

Zacks 5d ago

RARE

STLN
+19.06%
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation

GlobeNewswire 1mo ago

STLN
+19.06%
TOIIW
Oncology Institute Q2 Earnings Call Highlights

MarketBeat 3mo ago

STLN
+19.06%
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

GlobeNewswire 3mo ago

STLN
+19.06%
STLNW

Performance Overview

Return	STLN	S&P 500 (^GSPC)
YTD	+21.52%	+9.93%
1-Year	+22.03%	+11.84%
3-Year	+84.09%	+73.10%

Mobilize your Website

View Site in Mobile | Classic

Share by: